Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma

Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma

Veure altres versions (1)

Background Eosinophilic airway inflammation measured by using induced sputum is an important treatment stratification tool in patients with severe asthma. In addition, sputum eosinophilia has been shown to be associated with severe exacerbations and airflow limitation. Objectives We sought to identi...

Descripció completa

Dades bibliogràfiques
Autors principals:	Newby, C, Agbetile, J, Hargadon, B, Monteiro, W, Green, R, Pavord, I, Brightling, C, Siddiqui, S
Format:	Journal article
Idioma:	English
Publicat:	Mosby Inc. 2014

Ítems similars

Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma.
per: Newby, C, et al.
Publicat: (2014)

Temporal assessment of airway remodeling in severe asthma using quantitative computed tomography.
per: Gupta, S, et al.
Publicat: (2015)

Eosinophils in asthma and airway hyperresponsiveness.
per: Brightling, C, et al.
Publicat: (2004)

IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma.
per: Fairs, A, et al.
Publicat: (2010)

Multiple inflammatory hits and the pathogenesis of severe airway disease.
per: Pavord, I, et al.
Publicat: (2006)

The significance of eosinophilic airway inflammation in asthma
per: Pavord, I, et al.
Publicat: (2002)

Association between neutrophilic airway inflammation and airflow limitation in adults with asthma.
per: Shaw, D, et al.
Publicat: (2007)

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
per: Green, R, et al.
Publicat: (2006)

Exacerbations of severe asthma in patients treated with mepolizumab
per: Shrimanker, R, et al.
Publicat: (2018)

New insights into the relationship between airway inflammation and asthma.
per: Wardlaw, A, et al.
Publicat: (2002)

Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma.
per: Berry, M, et al.
Publicat: (2005)

Location, location, location: microlocalisation of inflammatory cells and airway dysfunction.
per: Brightling, C, et al.
Publicat: (2004)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
per: Brightling, C, et al.
Publicat: (2003)

Chapter 11. Mast cell localization within the airway smooth muscle: Relationship to airway hyperresponsiveness and other asthma phenotypes
per: Wardlaw, A, et al.
Publicat: (2004)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
per: Haldar, P, et al.
Publicat: (2014)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
per: Haldar, P, et al.
Publicat: (2014)

Mast-cell infiltration of airway smooth muscle in asthma.
per: Brightling, C, et al.
Publicat: (2002)

Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).
per: Agbetile, J, et al.
Publicat: (2014)

Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study)
per: Agbetile, J, et al.
Publicat: (2014)

Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design
per: Tim Harrison, et al.
Publicat: (2020-06-01)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
per: Bilocca, D, et al.
Publicat: (2017)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
per: Berry, M, et al.
Publicat: (2005)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
per: Haldar, P, et al.
Publicat: (2014)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
per: Haldar, P, et al.
Publicat: (2009)

Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.
per: Agbetile, J, et al.
Publicat: (2012)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
per: Kulkarni, N, et al.
Publicat: (2010)

Eosinophils in Asthma and Airway Hyperresponsiveness [3] (multiple letters)
per: Brightling, C, et al.
Publicat: (2004)

Biomarkers predicting response to corticosteroid therapy in asthma.
per: Brightling, C, et al.
Publicat: (2005)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
per: Shrimanker, R, et al.
Publicat: (2017)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
per: Green, R, et al.
Publicat: (2002)

Qualitative analysis of high-resolution CT scans in severe asthma.
per: Gupta, S, et al.
Publicat: (2009)

Sputum mediator profiling and relationship to airway wall geometry imaging in severe asthma
per: Desai Dhananjay, et al.
Publicat: (2013-02-01)

Asthma control, airway responsiveness and airway inflammation.
per: Pavord, I
Publicat: (2009)

Body mass and fat mass in refractory asthma: an observational 1 year follow-up study.
per: Bafadhel, M, et al.
Publicat: (2010)

The upper and lower airway microbiome in severe asthma
per: Jabeen, M, et al.
Publicat: (2022)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
per: Siva, R, et al.
Publicat: (2007)

A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma.
per: Shaw, D, et al.
Publicat: (2012)

Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes.
per: Gupta, S, et al.
Publicat: (2010)

Stability of inflammatory phenotypes in asthma.
per: Green, R, et al.
Publicat: (2012)

Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design
per: Lucia De Prado Gomez, et al.
Publicat: (2023-03-01)